mTOR inhibitors gaining favor for breast cancer treatment
Emory Health Now (blog)
Ruth O'Regan, MD, director of the Translational Breast Cancer Research Program at Winship Cancer Institute, has led clinical studies of everolimus in breast cancer and has championed the strategy of combining mTOR inhibitors with current treatments for ...
Two drugs appear to delay cancer progressionNews Chief
Experimental breast-cancer drugs show promiseNature.com (blog)
Big promise is seen in 2 new breast cancer drugseTaiwan News

all 1,977 news articles »